MYC and neoplasm: In vivo, the ATR inhibitor AZ20 was found to have anti-tumour efficacy against nude mice bearing LoVo colorectal tumour xenografts, with K-Ras mutation and expression of c-Myc, H-Ras, N-Ras, Myb and Fos oncogenes [71].